Phase II Study of Efgartigimod, a Novel FcRn Antagonist, in Adult Patients with Primary Immune Thrombocytopenia
Adrian C. Newland1, Blanca Sánchez-González2,3, László Rejtő4, et al.
1 Department of Haematology, Centre for Haematology, The Royal London Hospital, London, United Kingdom
2 Hematology Department, Hospital del Mar, Barcelona, Spain
3 Clinical Hematology Research Group, Hospital del Mar Medical Research Institute, Barcelona, Spain
4 Hematology Department, Josa András Teaching Hospital, Nyíregyháza, Hungary
Program: Oral and Poster Abstracts Type: Oral Session: 311. Disorders of Platelet Number or Function: Advances in ITP Therapy Hematology Disease Topics & Pathways: Adult, Antibodies, Biological, Autoimmune Disorders, Diseases, Therapies, Bleeding and Clotting, ITP, Study Population, Clinically Relevant Monday, December 9, 2019: 6:15 PM W307, Level 3 (Orange County Convention Center)...